A monoclonal antibody-based VZV glycoprotein E quantitative assay and its application on antigen quantitation in VZV vaccine

Verfasser / Beitragende:
[Jian Liu, Rui Zhu, Xiangzhong Ye, Lianwei Yang, Yongmei Wang, Yanying Huang, Jun Wu, Wei Wang, Jianghui Ye, Yimin Li, Qinjian Zhao, Hua Zhu, Tong Cheng, Ningshao Xia]
Ort, Verlag, Jahr:
2015
Enthalten in:
Applied Microbiology and Biotechnology, 99/11(2015-06-01), 4845-4853
Format:
Artikel (online)
ID: 605506221
LEADER caa a22 4500
001 605506221
003 CHVBK
005 20210128100626.0
007 cr unu---uuuuu
008 210128e20150601xx s 000 0 eng
024 7 0 |a 10.1007/s00253-015-6602-5  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00253-015-6602-5 
245 0 2 |a A monoclonal antibody-based VZV glycoprotein E quantitative assay and its application on antigen quantitation in VZV vaccine  |h [Elektronische Daten]  |c [Jian Liu, Rui Zhu, Xiangzhong Ye, Lianwei Yang, Yongmei Wang, Yanying Huang, Jun Wu, Wei Wang, Jianghui Ye, Yimin Li, Qinjian Zhao, Hua Zhu, Tong Cheng, Ningshao Xia] 
520 3 |a Varicella-zoster virus (VZV) is a highly infectious agent that causes varicella and herpes zoster (HZ), which may be associated with severe neuralgia. Vaccination is the most effective way to reduce the burden of the diseases. VZV glycoprotein E (gE) is the major and most immunogenic membrane protein that plays important roles in vaccine efficacy. A quantitative assay for gE content is desirable for the VZV vaccine process monitoring and product analysis. In this study, 70 monoclonal antibodies (mAbs) were obtained after immunizing mice with purified recombinant gE (rgE). The collection of mAbs was well-characterized, and a pair of high-affinity neutralization antibodies (capture mAb 4A2 and detection mAb 4H10) was selected to establish a specific and sensitive sandwich enzyme-linked immunosorbent assay (ELISA) to quantify the native and recombinant gE. The detection limit of this assay was found to be 1.95ng/mL. Furthermore, a reasonably good correlation between the gE content (as measured by the mAb-based quantitative ELISA) and the virus titer (as measured by the "gold standard” plaque assay) was observed when both assays were performed for tracking the kinetics of virus growth during cell culture. A total of 16 batches of lyophilized VZV vaccine were tested using the newly developed quantitative ELISA and classical plaque assay, demonstrating reasonably good correlation between gE content and virus titer. Therefore, this mAb-based gE quantitative assay serves as a rapid, stable, and sensitive method for monitoring viral antigen content, one additional quantitative method for VZV vaccine process and product characterization. This quantitative ELISA may also serve as a complementary method for virus titering. 
540 |a Springer-Verlag Berlin Heidelberg, 2015 
690 7 |a Varicella-zoster virus (VZV)  |2 nationallicence 
690 7 |a VZV vaccine  |2 nationallicence 
690 7 |a Glycoprotein E  |2 nationallicence 
690 7 |a Sandwich ELISA  |2 nationallicence 
690 7 |a Virus titer  |2 nationallicence 
700 1 |a Liu  |D Jian  |u State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, 361102, Xiamen, China  |4 aut 
700 1 |a Zhu  |D Rui  |u National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, 361102, Xiamen, China  |4 aut 
700 1 |a Ye  |D Xiangzhong  |u Beijing Wantai Biological Pharmacy Enterprise, 102206, Beijing, China  |4 aut 
700 1 |a Yang  |D Lianwei  |u Beijing Wantai Biological Pharmacy Enterprise, 102206, Beijing, China  |4 aut 
700 1 |a Wang  |D Yongmei  |u State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, 361102, Xiamen, China  |4 aut 
700 1 |a Huang  |D Yanying  |u National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, 361102, Xiamen, China  |4 aut 
700 1 |a Wu  |D Jun  |u State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, 361102, Xiamen, China  |4 aut 
700 1 |a Wang  |D Wei  |u State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, 361102, Xiamen, China  |4 aut 
700 1 |a Ye  |D Jianghui  |u National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, 361102, Xiamen, China  |4 aut 
700 1 |a Li  |D Yimin  |u Beijing Wantai Biological Pharmacy Enterprise, 102206, Beijing, China  |4 aut 
700 1 |a Zhao  |D Qinjian  |u National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, 361102, Xiamen, China  |4 aut 
700 1 |a Zhu  |D Hua  |u Department of Microbiology and Molecular Genetics, New Jersey Medical School, Rutgers University, 225 Warren Street, 070101, Newark, NJ, USA  |4 aut 
700 1 |a Cheng  |D Tong  |u State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, 361102, Xiamen, China  |4 aut 
700 1 |a Xia  |D Ningshao  |u State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, 361102, Xiamen, China  |4 aut 
773 0 |t Applied Microbiology and Biotechnology  |d Springer Berlin Heidelberg  |g 99/11(2015-06-01), 4845-4853  |x 0175-7598  |q 99:11<4845  |1 2015  |2 99  |o 253 
856 4 0 |u https://doi.org/10.1007/s00253-015-6602-5  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00253-015-6602-5  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Liu  |D Jian  |u State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, 361102, Xiamen, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Zhu  |D Rui  |u National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, 361102, Xiamen, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ye  |D Xiangzhong  |u Beijing Wantai Biological Pharmacy Enterprise, 102206, Beijing, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Yang  |D Lianwei  |u Beijing Wantai Biological Pharmacy Enterprise, 102206, Beijing, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Wang  |D Yongmei  |u State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, 361102, Xiamen, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Huang  |D Yanying  |u National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, 361102, Xiamen, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Wu  |D Jun  |u State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, 361102, Xiamen, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Wang  |D Wei  |u State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, 361102, Xiamen, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ye  |D Jianghui  |u National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, 361102, Xiamen, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Li  |D Yimin  |u Beijing Wantai Biological Pharmacy Enterprise, 102206, Beijing, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Zhao  |D Qinjian  |u National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, 361102, Xiamen, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Zhu  |D Hua  |u Department of Microbiology and Molecular Genetics, New Jersey Medical School, Rutgers University, 225 Warren Street, 070101, Newark, NJ, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Cheng  |D Tong  |u State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, 361102, Xiamen, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Xia  |D Ningshao  |u State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, 361102, Xiamen, China  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Applied Microbiology and Biotechnology  |d Springer Berlin Heidelberg  |g 99/11(2015-06-01), 4845-4853  |x 0175-7598  |q 99:11<4845  |1 2015  |2 99  |o 253